Skip to content
AnalystLens
Back to BBIOCash Flow

BridgeBio Pharma Free Cash Flow 2017-2026 | BBIO

Annual FY2017–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

−$447.0M

+14.3%YoY vs FY2024Source: 10-KFY2025

From −$41.0M in FY2017 to −$447.0M in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26−$197M+0.9%−$72M+12.0%−$44M+59.6%Not reported
FY25−$199M+9.5%−$81M−208.9%−$110M+39.1%−$56M+71.1%
FY24−$220M−52.6%$75M+165.6%−$181M−24.1%−$195M−56.0%
FY23−$144M+10.6%−$114M−246.3%−$146M−7.2%−$125M−33.2%
FY22−$161M−5.7%−$33M+65.0%−$136M−6.2%−$94M+31.1%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

N/A

FY2020
−$407.2M
FY2025
−$447.0M

5 years selected · on the chart

Free Cash Flow History

Year-over-year comparison from 10-K annual reports

  1. −$447.0M
YoY changeLargest recent move−239.0%in FY18Latest +14.3%

1 older move runs past ±150% (largest −239.0%); point at, tap or drag across the bars to read one.

Free Cash Flow, period by period

PeriodValueChangeSource
FY2025−$447.0M+14.3%10-K
FY2024−$521.7M+1.4%10-K
FY2023−$529.0M−24.7%10-K
FY2022−$424.3M+17.0%10-K
FY2021−$511.2M−25.5%10-K
FY2020−$407.2M−58.9%10-K
FY2019−$256.2M−84.6%10-K
FY2018−$138.8M−239.0%10-K
FY2017−$41.0M—10-K

What is BridgeBio Pharma's current free cash flow?

BridgeBio Pharma (BBIO) annual free cash flow for 2025 was $-447.0M, a 14.31% increase from 2024. BridgeBio Pharma free cash flow for the quarter ending September 30, 2026 was $-44.5M.

What was BridgeBio Pharma's free cash flow in 2024?

BridgeBio Pharma annual free cash flow for 2024 was $-521.7M, a 1.39% increase from 2023.

What was BridgeBio Pharma's free cash flow in 2023?

BridgeBio Pharma annual free cash flow for 2023 was $-529.0M, a 24.68% decline from 2022.

Company
BridgeBio Pharma
Ticker
BBIO
Sector
Healthcare
Industry
Pharmaceutical Preparations